ENTITY
Zai Lab Ltd

Zai Lab Ltd (ZLAB US)

136
Analysis
Health CareChina
Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.
more
14 Oct 2020 16:24

GDS Holdings Hong Kong Secondary - Hot Sector, Needs the Money

Gds Holdings (Adr) (GDS US) plans to raise around US$1bn in its secondary listing in Hong Kong. Media reports indicate that the deal could be...

Logo
386 Views
Share
04 Oct 2020 12:46

ECM Weekly (4 October 2020) - JD Health, MINISO, Everest Med, Weihai Comm Bank, JD Digits

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
28 Sep 2020 10:43

ZTO Express Secondary Trading - Insti Little Weaker, Retail Little Stronger but Doing Well so Far

ZTO Express (ZTO US) plans to raise around US$1.4bn in its secondary listing in Hong Kong. While the company filed its PHIP on Friday, 11th Sep...

Logo
237 Views
Share
bullishChindata Group
27 Sep 2020 08:46

ECM Weekly (27 September 2020) - Ant Group, Chindata, SCG Packaging, JHBP/Genor, Neuedu, UTI AMC

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Deal...

Share
x